1. Advances in Renal Cell Carcinoma Drug Resistance Models
   Yien Xiang et al, 2022, Frontiers in Oncology CrossRef
2. High Immunoexpression of COX-2 as a Metastatic Risk Factor in ccRCC without PD-L1 Involvement
   Sri Suryanti et al, 2021, Research and Reports in Urology CrossRef
3. Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics
   Yunxia Wang et al, 2023, British Journal of Pharmacology CrossRef